Published in AIDS Weekly and Law, March 18th, 2004
"The synthetic immunomodulator murabutide has been found to suppress human immunodeficiency virus type-1 (HIV-1) replication, in macrophages, through a regulated expression of cellular factors needed at different steps in the virus replication cycle," virologists in France explained.
"To identify cellular genes implicated in the murabutide-induced virus inhibition," M.J. Truong and colleagues working at the Pasteur Institute in Lille "carried out a differential display analysis on HIV-1-infected macrophages that were treated, or not, with murabutide."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly and Law
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.